Literature DB >> 6792175

Directed biosynthesis of new indolmycins.

R G Werner, A L Demain.   

Abstract

Tryptophan in a concentration of 0.4 microgram/ml increased the production of indolmycin by 37%. The lipophilic character of indolmycin was reduced via directed biosynthesis by substituting the aromatic ring system with a methoxy or hydroxy group in the 5-position of the antibiotic. This substitution was achieved by the addition of the corresponding tryptophan and indole precursors to a growing culture of Streptomyces griseus ATCC 12648. The more hydrophilic indolmycin derivatives displayed a moderate increase in antimicrobial activity as compared to indolmycin, but did not markedly change the Gram-positive/Gram-negative ratio of activity. Thin-layer chromatography and mass spectrometry showed that additives substituted in the 6-position were not incorporated into the molecule. Antibiotic titer was reduced by addition of the modified precursors, especially in the case of the precursors substituted in the 6-position.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6792175     DOI: 10.7164/antibiotics.34.551

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  4 in total

Review 1.  Prospects for aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents.

Authors:  Julian Gregston Hurdle; Alexander John O'Neill; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

2.  In vitro reconstitution of indolmycin biosynthesis reveals the molecular basis of oxazolinone assembly.

Authors:  Yi-Ling Du; Lona M Alkhalaf; Katherine S Ryan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-17       Impact factor: 11.205

3.  A novel tryptophanyl-tRNA synthetase gene confers high-level resistance to indolmycin.

Authors:  James J Vecchione; Jason K Sello
Journal:  Antimicrob Agents Chemother       Date:  2009-06-22       Impact factor: 5.191

4.  An engineered biosynthetic-synthetic platform for production of halogenated indolmycin antibiotics.

Authors:  Elesha R Hoffarth; Sunnie Kong; Hai-Yan He; Katherine S Ryan
Journal:  Chem Sci       Date:  2021-06-01       Impact factor: 9.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.